IP Library › Granted Patent US 9,446,259
Granted Patent B2
US 9,446,259 · App. 14/051,378 · Granted Sep 20, 2016

Systems and methods for neuro-EEG synchronization therapy

Inventors: James William Phillips (Fountain Valley, CA); Yi Jin (Irvine, CA)
Assignee: Neosync, Inc.
A61N2/008A61B5/048A61B5/4029A61B5/4076A61N2/004A61B5/407A61B5/4035A61B5/7257A61B2560/0468
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,446,259
App. No.
14/051,378
Granted
Sep 20, 2016
Kind
B2
Abstract

Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for a number of disorders. Described are methods and devices to treat disorders that involves no medication. Methods and devices described herein use alternating magnetic fields to gently “tune” the brain and affect mood, focus, and cognition of subjects.

Claims (41)

1. A method comprising:

generating output of a magnetic field based on an intrinsic frequency of a specified EEG band of a subject, a Q-factor of the intrinsic frequency within the specified EEG band of the subject, or both comprising:

generating the magnetic field having a first frequency that is higher than the intrinsic frequency in the specified EEG band of the subject in order to move the intrinsic frequency of the subject up within the specified EEG band toward a preselected intrinsic frequency;

generating the magnetic field having a second frequency that is lower than the intrinsic frequency in the specified EEG band of the subject in order to move the intrinsic frequency of the subject down within the specified EEG band toward the preselected intrinsic frequency;

generating the magnetic field having a first pre-selected frequency in order to move the Q-factor of the intrinsic frequency within the specified EEG band up toward a preselected Q-factor;

generating the magnetic field having a second pre-selected frequency in order to move the Q-factor of the intrinsic frequency within the specified EEG band down toward the preselected Q-factor;

generating the magnetic field having a plurality of frequencies within the specified EEG band in order to move the Q-factor of the intrinsic frequency within the specified EEG band down toward the preselected Q-factor;

or a combination thereof;

applying the output of the magnetic field to a head of the subject, wherein application of the output of the magnetic field improves at least one of

neuropathic pain in the subject,

a neurological disorder in the subject,

a symptom of brain damage, and

brain dysfunction in the subject.

2. The method of claim 1 ,

wherein the neuropathic pain comprises at least one of: occipital neuralgia, neuritis, trigeminal neuralgia, peripheral neuralgia, sciatic neuralgia, intercostal neuralgia, postherpetic neuralgia, diabetic neuropathy, and glossopharyngeal neuralgia;

wherein the neurological disorder comprises at least one of: a brain neurological disorder, a spinal cord disorder, a peripheral nervous system disorder, a cranial nerve disorder, an autonomic nervous system disorder, a seizure disorder, a movement disorder, a sleep disorder, a headache, lower back pain, neck pain, other generalized neuropathic pain, delirium, dementia, dizziness, vertigo, stupor, coma, a head injury, a stroke, multiple sclerosis, a demylenating disease, an infection of the brain or spinal cord, a prion disease, and a complex regional pain syndrome;

wherein the brain damage comprises at least one of: cerebral lobe damage including lower brain areas, frontal lobe damage, parietal lobe damage, temporal lobe damage, and occipital lobe damage; and

wherein the brain dysfunction comprises at least one of: aphasia, dysarthria, apraxia, agnosia, and amnesia.

3. The method of claim 1 , further comprising taking EEG measurements of the subject before the applying step or after the applying step, or both before the applying step and after the applying step.

4. The method of claim 1 , further comprising determining at least one of: the subject's intrinsic frequency of the specified EEG band and the subject's Q-factor of an intrinsic frequency within the specified EEG band.

5. The method of claim 1 , wherein the application of the output of the magnetic field is to a diffuse area in a brain of the subject.

6. The method of claim 1 , wherein the magnetic field is generated by movement of at least one permanent magnet.

7. The method of claim 6 , wherein the strength of the at least one permanent magnetic is from about 10 Gauss to about 4 Tesla.

8. A device comprising:

at least one permanent magnet, wherein movement of the at least one permanent magnet generates a magnetic field;

a subunit comprising a motor coupled to the at least one permanent magnet and logic comprising a processor and computer program executable by the processor, wherein the logic controls adjustment of the magnetic field by the subunit and moves at least one of:

an intrinsic frequency of a specified EEG band of a subject toward a pre-selected intrinsic frequency of the specified EEG band based on the intrinsic frequency of the specified EEG band of the subject; and

a Q-factor of the intrinsic frequency within the specified EEG band of the subject toward a pre-selected Q-factor based on the Q-factor of the intrinsic frequency within the specified EEG band of the subject,

wherein the subunit is configured to apply said magnetic field close to a head of the subject, and wherein at least one of the pre-selected intrinsic frequency and the pre-selected Q-factor is chosen in order to improve at least one of:

neuropathic pain in the subject,

a neurological disorder in the subject,

a symptom of brain damage, and

brain dysfunction in the subject.

9. The device of claim 8 ,

wherein the neuropathic pain comprises at least one of: occipital neuralgia, neuritis, trigeminal neuralgia, peripheral neuralgia, sciatic neuralgia, intercostal neuralgia, postherpetic neuralgia, diabetic neuropathy, and glossopharyngeal neuralgia;

wherein the neurological disorder comprises at least one of: a brain neurological disorder, a spinal cord disorder, a peripheral nervous system disorder, a cranial nerve disorder, an autonomic nervous system disorder, a seizure disorder, a movement disorder, a sleep disorder, a headache, lower back pain, neck pain, other generalized neuropathic pain, delirium, dementia, dizziness, vertigo, stupor, coma, a head injury, a stroke, multiple sclerosis, a demylenating disease, an infection of the brain or spinal cord, a prion disease, and a complex regional pain syndrome;

wherein the brain damage comprises at least one of: cerebral lobe damage including lower brain areas; frontal lobe damage, parietal lobe damage, temporal lobe damage, and occipital lobe damage; and

wherein the brain dysfunction comprises at least one of: aphasia, dysarthria, apraxia, agnosia, and amnesia.

10. The device of claim 8 , wherein the strength of the at least one permanent magnetic is from about 10 Gauss to about 4 Tesla.

11. The device of claim 10 , wherein movement of the at least one said magnet generates an alternating magnetic field.

12. The device of claim 8 , comprising a helmet, wherein the subunit is in the helmet and is configured to adjust the magnetic field to be any frequency between about 0.5 Hz and about 100 Hz in increments of about 0.1 Hz.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: NEOSYNC, INC.
To: WAVE NEUROSCIENCE, INC.
Reel/Frame 052108/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2014
From: PHILLIPS, JAMES WILLIAM; JIN, YI
To: NEOSYNC, INC.
Reel/Frame 033122/0828 →
Continuity (3)
Division 12942922 · Nov 9, 2010
Provisional Application 61260779 · Nov 12, 2009
Related Publication 20140179980A1 · Jun 26, 2014